The RTS,S vaccine-a chance to regain the upper hand against malaria?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35245476.
- Also identified by DOI 10.1016/j.cell.2022.01.028 and PMC identifier 11629154.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malaria is estimated by the World Health Organization (WHO) to have killed 627,000 individuals worldwide in 2020, with nearly 80% of deaths in African children younger than five. The recent WHO approval of the RTS,S/AS01 vaccine, which targets Plasmodium falciparum pre-erythrocytic stages, provides hope that its use combined with other interventions can help reverse the current malaria resurgence.
Medical subject headings
- Malaria
- Malaria Vaccines
- Malaria, Falciparum